The Indian market for cardiovascular devices is anticipated to expand at a compound annual growth rate (CAGR) of 5% between 2022 and 2030. According to a statement from Global Data, the industry would continue to be driven by research and development of cutting-edge technology.

The data and analytics company reported that the recently released Optima IGS 320 by GE Healthcare interventional cardiology system, the first artificial intelligence (AI) enabled Cath lab diagnostic imaging platform to be made in India can better direct non-invasive cardiovascular procedures with greater precision and adaptability.

Mr. Shachee Singh, Medical Devices Analyst at GlobalData, stated that there is a need for reasonably priced technology to keep up with the nations growing preference for less invasive methods of treating CVDs. Through automation of complex cardiac and electrophysiology operations and sophisticated imaging, products like the Optima IGS 320 will assist patients individualized treatment plans with higher precision.

He continued that it is a reasonably priced visualization and imaging device with built-in AutoRight technology that uses neural networks to improve dose settings in real time. When performing dangerous operations, features like the PCI ASSIST will enhance the quality of the pictures, making it the perfect choice for complex cardiac therapeutic interventions.

(Source: https://health.economictimes.indiatimes.com/news/medical-devices/automated-cath-labs-to-enhance-cardiovascular-care-in-india-global-data/95161637)